Clinical Report: Advanced Brain Tumor Care, Close to Home
Overview
The Marcus Neuroscience Institute offers a multidisciplinary approach to brain tumor care, integrating advanced technologies and specialized teams.
Background
Brain tumors present significant challenges in diagnosis and treatment, often requiring a coordinated approach to care.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
- The Marcus Neuroscience Institute provides a multidisciplinary team approach for brain tumor patients.
- Advanced technologies such as minimally invasive surgery and intraoperative MRI are utilized.
- Patients can often be seen within 24 hours for urgent brain tumor concerns.
- Proton therapy is available.
- Comprehensive care includes access to clinical trials and supportive therapies.
Clinical Implications
The multidisciplinary model at Marcus Neuroscience Institute highlights the importance of coordinated care in managing brain tumors. Timely access to specialized services can significantly impact patient experiences and outcomes.
Conclusion
The integration of advanced treatment options and a collaborative care team at Marcus Neuroscience Institute represents a significant advancement in brain tumor management, providing patients with comprehensive support close to home.
Related Resources & Content
- The ASCO Post, 2013 -- Improving Treatment and Care for Patients with Primary Brain Cancers
- Journal of Neuro-Oncology, 2017 -- Neuro-oncology family caregivers’ view on keeping track of care issues using eHealth systems: it’s a question of time
- The ASCO Post, 2013 -- Association of Community Cancer Centers' 2013 Innovator Award Recipients Announced
- Journal of Clinical Oncology, 2025 -- Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update
- ASTRO, 2025 -- ASTRO updates guideline on radiation therapy for high-grade diffuse glioma
- atlantic health system — Advanced Breast Imaging Backed by Specialized Clinical Care
- Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update | Journal of Clinical Oncology
- ASTRO updates guideline on radiation therapy for high-grade diffuse glioma - American Society for Radiation Oncology (ASTRO)
- Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of surgery in the management of patients with diffuse low grade glioma: update - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
